Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and Rosuvastatin in Osteoporotic Patients
NCT07717788Completed
- Sponsor
- University of Kufa College of Pharmacy
- Start
- Feb 2025
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label trial of atorvastatin and rosuvastatin in osteoporosis (3 arms), sponsored by University of Kufa College of Pharmacy. Primary endpoints: Bone Mineral Density at 6 months, Serum Calcium and Vitamin D levels at 6 months and 1 more. Started Feb 2025; status: completed.
02
Drugs
atorvastatinrosuvastatin
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07717788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07717788.